HIF-1'alfa' and locally advanced breast cancer [Carta] (2010)
- Authors:
- USP affiliated authors: TIÉZZI, DANIEL GUIMARÃES - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; SILVA, JOÃO SANTANA DA - FMRP
- Unidade: FMRP
- Assunto: NEOPLASIAS MAMÁRIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: The Breast Journal
- ISSN: 1075-122X
- Volume/Número/Paginação/Ano: v. 16, n. 5, p. 569-570, 2010
-
ABNT
MARANA, Heitor Ricardo Cosiski et al. HIF-1'alfa' and locally advanced breast cancer [Carta]. The Breast Journal. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 27 dez. 2025. , 2010 -
APA
Marana, H. R. C., Tiezzi, D. G., Andrade, J. M. de, & Silva, J. S. da. (2010). HIF-1'alfa' and locally advanced breast cancer [Carta]. The Breast Journal. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Marana HRC, Tiezzi DG, Andrade JM de, Silva JS da. HIF-1'alfa' and locally advanced breast cancer [Carta]. The Breast Journal. 2010 ; 16( 5): 569-570.[citado 2025 dez. 27 ] -
Vancouver
Marana HRC, Tiezzi DG, Andrade JM de, Silva JS da. HIF-1'alfa' and locally advanced breast cancer [Carta]. The Breast Journal. 2010 ; 16( 5): 569-570.[citado 2025 dez. 27 ] - IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Cancer stem cells and lymph node metastasis in early stage breast cancer
- VEGF and HIF-1 alpha plasma level as prognostic factor in locally advanced breast cancer submitted to neoadjuvant chemotherapy
- Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
